Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Adam on +441494 818 010 or adam@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Adam Woolley
Recruitment Consultant
adam@zenopa.com
+441494 818 010

Testimonials
Working as a hospital specialist contractor for Zenopa has been a very positive experience. My contract manager was great. I genuinely felt she was on my side wanting me to do well.
Sadie, 2011

Sanofi 'launches bid for Merck's consumer health unit'

25 March 2014 10:48 in Pharmaceutical Company Restructures


Sanofi \'launches bid for Merck\'s consumer health unit\'Sanofi has reportedly become the latest pharmaceutical company to launch a bid for Merck's consumer-health products division.

This is according to a report from Bloomberg, which suggests the unit - responsible for the Coppertone sun lotion and Claritin allergy brands - could be valued at $10 billion to $12 billion (6.06 billion to 7.27 billion pounds). 

Final bids are expected to be submitted next week, with Reckitt Benckiser also thought to be among the aggressive bidders.

A number of pharmaceutical companies have been attempting to spin off businesses they assess to be growing too slowly in an effort to focus on the development of new drugs. 

Merck's over-the-counter division saw its sales drop by three percent to $1.9 billion last year, with almost one quarter of revenues coming from Claritin.

Sanofi's allergy medicine Allegra led its consumer products sales, which totalled $4.1 billion in 2013. Chief executive Chris Viehbacher took up the role in 2008 and drove the $20.1 billion acquisition of Genzyme in 2011.ADNFCR-8000103-ID-801706259-ADNFCR

Other news stories from 25/03/2014

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd